Condition
Hypopigmentation
Total Trials
4
Recruiting
0
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
Early P 1 (1)
Trial Status
Not Yet Recruiting1
Active Not Recruiting1
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06908889Not ApplicableActive Not RecruitingPrimary
Characterization of Bacterial and Mycosis Skin Flora in Seborrheic Macular Hypopigmentation - Microbiome
NCT07837908Not ApplicableNot Yet Recruiting
Fractional CO2 Laser vs Dermabrasion With 5-Fluorouracil for Acquired Leukoderma
NCT04971200Early Phase 1Completed
Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo
NCT00771355Terminated
In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy
Showing all 4 trials